Bivalirudin cardiopulmonary bypass
WebView bivalirudin information, including dose, uses, side-effects, renal impairment, pregnancy, breast feeding, ... in patients proceeding to percutaneous coronary intervention or coronary artery bypass surgery without cardiopulmonary bypass for bivalirudin Initially by intravenous injection. Adult Initially 100 micrograms/kg for 1 dose, then ... WebThe hypothesis that dabigatran would provide sufficient anticoagulation for cardiopulmonary bypass was tested in a first-use, proof-of-concept study using a rabbit …
Bivalirudin cardiopulmonary bypass
Did you know?
WebTY - JOUR T1 - Use of bivalirudin as an anticoagulant during cardiopulmonary bypass. AU - Veale,James J, AU - McCarthy,Harry M, AU - Palmer,George, AU - Dyke,Cornelius M, PY - 2005/12/15/pubmed PY - 2006/2/8/medline PY - 2005/12/15/entrez SP - 296 EP - 302 JF - The journal of extra-corporeal technology JO - J Extra Corpor Technol VL - 37 IS - 3 … WebInfants with heparin-induced thrombocytopenia (HIT) represent a challenging and high-risk group of patients when they require cardiopulmonary bypass (CPB). Bivalirudin offers many potential pharmacologic advantages over other nonheparin anticoagulants for such patients. We describe our protocol for …
WebHeparin is used to provide anticoagulation during cardiopulmonary bypass, but it has disadvantages including potential development of antiplatelet factor 4/heparin antibodies. A recommended alternative to heparin, bivalirudin, has its own disadvantages including the lack of a reversal agent. Dabigatran may be a better alternative in patients ... WebBackground: The coronary artery bypass grafting (CABG) heparin-induced thrombocytopenia thrombosis syndrome (HITTS) on- and off-pump safety and efficacy …
WebFeb 3, 2024 · A typical adult based bivalirudin regimen during cardiopulmonary bypass uses a loading dose of 1 mg.kg ‐1 and a circuit prime (volume L x 13 mg) with a subsequent intravenous infusion 2.5 mg.h ‐1 .kg ‐1. Dose in children remains unknown. We wished to determine a practical bivalirudin dosing schedule for children undergoing surgery with ... WebFeb 1, 2004 · We investigated the use of bivalirudin as an anticoagulant therapy during cardiopulmonary bypass in 20 patients who underwent coronary artery bypass …
WebReverso Context oferă traducere în context din engleză în română pentru "artery bypass graft surgery", cu exemple: Following coronary artery bypass graft surgery, patients administered Dynastat have a higher risk of adverse events, such as cardiovascular/ thromboembolic events, deep surgical infections and sternal wound healing complications.
WebApr 1, 2010 · ObjectiveTo evaluate the use of recombinant factor VIIa (rFVIIa) to reverse major bleeding from newer parenteral anticoagulant therapy.Data sourcesMEDLINE/PubMed was searched from January 2000 through December 2009 using the terms recombinant factor VIIa, rFVIIa, NovoSeven, enoxaparin, argatroban, … radio nihuil 98.9 fmWebNov 3, 2010 · Antiphospholipid syndrome (APLS) is a rare syndrome mainly characterized by several hyper-coagulable complications and therefore, implicated in the operated cardiac surgery patient. APLS comprises clinical features such as arterial or venous thromboses, valve disease, coronary artery disease, intracardiac thrombus … dragon j20WebDec 15, 2024 · Bivalirudin reference guide for safe and effective use from the American Society of Health-System Pharmacists (AHFS DI). ... During “off-pump” cardiac surgery (i.e., without cardiopulmonary bypass), 0.75 mg/kg by direct IV injection, followed by 1.75 mg/kg per hour by continuous IV infusion to maintain an ACT >300 seconds has been used. radio nihonWebFeb 1, 2024 · However, pharmacokinetic studies during cardiac surgery are only available for bivalirudin. 11,12 During surgery with … dragonjackWebJun 19, 2024 · On-pump:Initial bolus: 1 mg/kg, followed by continuous infusion 2.5 mg/kg/hour; 50 mg bolus added to priming solution of cardiopulmonary bypass (CPB) circuit. Additional boluses of 0.1 to 0.5 mg/kg may … dragon jack o posedragonja grenzübergangWebAnesthesia & Analgesia: June 2004 - Volume 98 - Issue 6 - p 1635-1639. doi: 10.1213/01.ANE.0000114072.71353.D5. Free. We treated persistent hemorrhage after cardiopulmonary bypass in a heart transplant recipient who had received anticoagulation with the direct thrombin inhibitor bivalirudin by a combination therapy aimed at reducing … radio nihuil 680